NCT02002832 A Clinical Trial of Lurasidone in Treatment of Schizophrenia Status COMPLETED Phase PHASE3
NCT02001103 Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia Status UNKNOWN Phase PHASE3
NCT01999309 Simvastatin Addition for Patients With Recent-onset Schizophrenia Status COMPLETED Phase PHASE3
NCT01998516 Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder Status COMPLETED Phase N/A
NCT01995864 Critical Time Intervention-Task Shifting: Randomized Controlled Trial Status COMPLETED Phase NA
NCT01994473 Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT01992393 Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME) Status COMPLETED Phase NA
NCT01981811 Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder Status WITHDRAWN Phase PHASE2
NCT01981759 D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions Status COMPLETED Phase PHASE4
NCT01979679 A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone Status COMPLETED Phase PHASE3
NCT01972711 Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics Status COMPLETED Phase PHASE1
NCT01971073 Transcranial Direct Current Stimulation Influences on Cognitive Inhibition in Schizophrenia Status TERMINATED Phase NA
NCT01969500 Development of a Mobile System for Self-management of Schizophrenia (SOS) Status COMPLETED Phase NA
NCT01967667 Biological Evaluation of Dietary Supplement Liposomal Glutathione Status COMPLETED Phase NA
NCT01964404 Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment? Status COMPLETED Phase PHASE1
NCT01963676 Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia Status COMPLETED Phase NA